| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7fd15d8ebb22202b5cfe2b109cd922c5 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-497 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-497 |
| filingDate |
2010-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_055b69a863f017137eb24da931a028a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b1c469bcfd659c9cb2d8a65b3837e6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_392bc832e89a8f9b0a69360496a11d7c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1e452cc1926128a0579df660b7da414 |
| publicationDate |
2011-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20110090057-A |
| titleOfInvention |
Pharmaceutical composition for the prevention and treatment of inflammatory diseases |
| abstract |
The present invention relates to 2-chloro-N 6- (3-iodobenzyl) -4′-thioadenosine-5′-N-methyluronamamide (thio-Cl-IB-MECA) or a pharmaceutically acceptable thereof. It relates to a pharmaceutical composition for the prophylaxis or treatment of inflammatory diseases comprising a salt of as an active ingredient. The pharmaceutical composition according to the present invention is significantly lower in toxicity compared to the conventional A 3 adenosine receptor agonist, which is useful for the prevention and treatment of inflammatory diseases. |
| priorityDate |
2010-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |